Wearable AI device for daily radiation therapy guidance
Part of Cancer clinical trials.
This trial tests a wearable device that uses artificial intelligence to help guide radiation therapy for pelvic cancers. The device may help make daily treatments more accurate, which could improve outcomes and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to be able to drink water and have a full bladder before treatment.
- You must be getting radiation therapy for a pelvic cancer, like prostate, bladder, cervical, or rectal cancer.
- You must be willing to sign a consent form.
- You cannot have had an allergic reaction to ultrasound gel in the past.
- The device needs to be placed on your skin, so you cannot have too much body hair or other physical limitations that prevent this.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called Flyte to see if it can help improve urinary incontinence in women who have had radiation therapy for endometrial or cervical cancer. You might join if you've had bladder control problems since your treatment.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
This trial tests whether using MRI scans daily during pelvic radiation therapy improves treatment precision and outcomes for endometrial cancer patients who need radiation after surgery. The goal is to better target cancer while reducing side effects.
This study tests if using a wearable activity tracker during radiation therapy can help reduce hospitalizations. It may help you stay healthier during treatment.
This trial tests a new way to give radiation therapy using MRI imaging and ultrasound to make the radiation more targeted and potentially safer. If you have chest-wall or breast cancer and are already scheduled for radiation, this approach might offer a more precise treatment option.
This study looks at whether information from wearable devices can help doctors better care for patients receiving chemotherapy and radiation together. It aims to improve treatment and quality of life.
Hear when a new Pelvic Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.